Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans

Heart

Volumn 83, Issue 6, 2000, Pages 688-695

  Heesch, C M ^a   Wilhelm, C R ^b   Ristich, J ^b   Adnane, J ^b   Bontempo, F A ^a   Wagner, W R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cocaine; Flow cytometry; Myocardial infarction; Platelets

Indexed keywords

COCAINE; PADGEM PROTEIN; PLACEBO; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLEEDING TIME; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FLOW CYTOMETRY; HEMODYNAMIC MONITORING; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0034042476     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.6.688     Document Type: Article

References (42)

1. Kolodgie FD, Farb A, Virmany R. Pathobiological determinants of cocaine-associated cardiovascular syndromes. Hum Pathol 1995;26:583-6.
2. Kloner RA, Hale S, Alker K, et al. The effects of acute and chronic cocaine use on the heart. Circulation 1992;85:407-19.
3. Kolodgie FD, Virmani R, Cornhill, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol 1991;17: 1553-60.
4. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-18.
5. Riggs D, Weibly RE. Acute hemorrhagic diarrhea and cardiovascular collapse in a young child owing to environmentally acquired cocaine. Pediatr Emerg Care 1991;7:154-5.
6. Murray RJ, Albin RJ, Mergner W, et al. Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest 1988;93:427-9.
7. Bailey ME, Fraire AE, Greenberg SD, et al. Pulmonary histopathology in cocaine abusers. Hum Pathol 1994;25: 203-7.
8. Anderton JM, Nassar WY. Topical cocaine and general anaesthesia: an investigation of the efficacy and side effects of cocaine on the nasal mucosae. Anaesthesia 1975;30:809-17.
9. Rezkalla SH, Mazza JJ, Kloner RA, et al. Effects of cocaine on human platelets in healthy subjects. Am J Cardiol 1993; 72:243-6.
10. Kugelmass AD, Oda A, Monahan K, et al. Activation of human platelets by cocaine. Circulation 1993;88:876-83.
11. Rinder HM, Ault KA, Jatlow PI, et al, Platelet α-granule release in cocaine users. Circulation 1994;90:1162-7.
12. Jennings LK, White MM, Sauer CM, et al. Cocaine-induced platelet defects. Stroke 1993;24:1352-9.
13. Togna G, Tempesta E, Togna AR, et al. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis 1985;15:100-7.
14. Kugelmass AD, Shannon RP, Yeo EL, et al. Intravenous cocaine induces platelet activation in the conscious dog. Circulation 1995;91:1336-40.
15. Kugelmass AD, Ware JA. Cocaine and coronary artery thrombosis [letter]. Ann Intern Med 1992;116:776-7.
16. Eichhorn EJ, Demian SE, Alvarez LG, et al. Cocaine-induced alterations in prostaglandin production in rabbit aorta. J Am Coll Cardiol 1992;19:696-703.
17. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med 1995;333:1267-72.
18. Abrams CS, Ellison N, Budzynski AZ, et al. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-38.
19. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 1987;70:307-15.
20. Niewiarowski S, Holt JC, Cook JJ. Biochemistry and physiology of secreted platelet proteins. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott, 1994:546-56.
21. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidlv lose surface p-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996;93:11877-82.
22. Rinder HM, Bonan JL, Rinder CS, et al. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78: 1730-7.
23. Rinder HM, Bonan JL, Rinder CS, et al. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78:1760-9.
24. O'Brien, JR. The adhesiveness of platelets and its prevention. J Clin Pathol 1961;14:140-9.
25. O'Brien JR. Platelet aggregation. J Clin Pathol 1962;15:446-55.
26. Aledort LM, Niemetz J. Dissociation of platelet aggregation from clot retraction, potassium loss, and adenosine triphosphatase activity. Proc Soc Exp Biol Med 1968;128:658-60.
27. Geerdink P, Levy-Toledano S, Wessels H, et al. Influence of lithium on aggregation, release-reaction and function of human platelets. Pathol Biol 1972;20(suppl):15-27.
28. Heesch CM, Steiner M, Hernandez JA, et al. Effects of cocaine on human platelet aggregation in vitro. J Toxicol Clin Toxicol 1996;34:673-84.
29. Heesch CM, Negus BH, Steiner M, et al. Effects of in vivo cocaine administration on human platelet aggregation. Am J Cardiol 1996;78:237-9.
30. O'Brien JR, Etherington MD, Shuttleworth RD, et al. Platelet function in acute myocardial infarction patients compared with controls. Thromb Haemost 1980;44:96-9.
31. Blann AD. Is raised von Willebrand factor a marker of endothelial cell damage? Med Hypotheses 1993;41:419-24.
32. Blann AD, McCollum CN. Von Willebrand factor, endothelial cell damage and atherosclerosis. Eur J Vasc Surg 1994;8:10-15.
33. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995;90:244-8.
34. Moliterno DJ, Lange RA, Gerard RD, et al. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med 1994;96:492-6.
35. Wiggins RC, Rolsten C, Ruiz B, et al. Pharmacokinetics of cocaine: basic studies of route, dosage, pregnancy and lactation. Neurotoxicology 1989;10:367-82.
36. Boelsterli UA, Göldlin C. Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch Toxicol 1991;65:351-60.
37. Heng MCY, Haberfeld G. Thrombotic phenomena associated with intravenous cocaine. J Am Acad Dermatol 1987;16:462-8.
38. Slack SM, Jennings LK, Turitto VT. Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation. Ann Biomed Eng 1994;22:653-9.
39. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol 1992;120:90-3.
40. Brogan WC, Lange RA, Glamann B, et al. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 1992;116:556-61.
41. Brogan WC, Lange RA, Kim AS, et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991;18:581-6.
42. Lange RA, Cigarroa RG, Yancy CW, et al. Cocaine-induced coronary artery vasoconstriction. N Engl J Med 1989;321: 1557-62.